Latest BioAlps news
News
CSEM and the EPFL spin-off ORYL Photonics win first prize at the 2026 EARTO Innovation Awards
On 10 June 2026, CSEM received the EARTO Innovation Award in the “Impact Expected” category for the development of a…
News
Crìa Technologies Winners of a 2026 W.A. de Vigier Award
A Geneva-area startup has earned a place among Switzerland’s most prestigious recognitions for young entrepreneurs. Crìa Technologies SA, based in…
News
Atinary Selected as a 2026 Technology Pioneer by the World Economic Forum
Atinary, a pioneer in Self-Driving Labs® has been selected as a 2026 Technology Pioneer by the World Economic Forum. The…
News
Symbios Finalist of The Swiss Medtech Award
The Swiss Medtech Award was presented on 10 June 2026 in Bern during the Swiss Medtech Day. Swiss Health Valley…
News
UNIGE Awards 2026 3R Prize for AI Tool Predicting Cancer Metastasis Risk
The prize, presented June 9 at the University of Geneva Faculty of Medicine’s annual ceremony, honors the development of MangroveGS,…
News
Impli Secured £1.4 million from the NIHR
Impli, a deep-tech company spun out of Imperial College London with a presence at Biopôle Lausanne, has just secured £1.4…
News
Fighting Age-Related Vision Loss: Fribourg Scientists Unlock a Cellular Recycling Key
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in people over 50 across industrialized countries…
News
Givaudan Acquires Eurofragrance
Givaudan, The Vernier-based (Canton of Geneva) global leader in Fragrance & Beauty, announced that it has reached an agreement to…
News
NETRIS Pharma Secures €7.25 Million in EU Horizon Europe Funding
NETRIS Pharma, a clinical-stage oncology company with roots in Lyon since 2008 and a Geneva presence since 2016, has announced…
News
TheraPPI closes Pre-Seed Financing Round
TheraPPI, a preclinical biotech company operating both in Lyon (France) and Geneva (Switzerland), announced the second closing of its Pre-Seed financing….
News
Isomorphic Labs Raises $2.1 Billion to Scale Its AI-Powered Drug Design Engine
Isomorphic Labs, the Google DeepMind spin-off on a mission to “solve all disease” with artificial intelligence, has secured $2.1 billion…
News
Oculis Announced Disappointing Results For its OCS-01 Eye Drops
The Vaud-based company, which specializes in neuro-ophthalmology and ophthalmology, stated that the primary endpoint of the DIAMOND trials was not…











